AI framework could enhance continuous manufacturing, say FDA researchers
Digital twin model offers potential for advanced control during continuous pharmaceutical manufacturing processes.
List view / Grid view
Digital twin model offers potential for advanced control during continuous pharmaceutical manufacturing processes.
Pharma giant plans to harness its “decades of data” and use AI to set a new scientific standard that accelerates pharmaceutical innovation.
Pistoia Alliance survey also found that the greatest benefit for lab digitalisation has shifted from efficiency to innovation.
The University of Cambridge and A*STAR platform aims to enhance fault detection, system monitoring and predictive maintenance.
New digital initiative will support the pharma company’s manufacturing and supply chain ambitions.